Multiple myeloma trials in South Africa

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

  Where

  Cape Town, Centurion, Kuilsriver, Plumstead

  Age

  18 years and over

  People

  810 worldwide

  Run by

  Celgene

  See details and how to joinNCT05519085
• Phase 1/2Taking people
  A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

  Where

  Kuils River

  Age

  18 years and over

  People

  123 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT05714839 · EU 2022-501941-63-00
• Phase 3Taking people
  A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

  Where

  Kuils River, Pretoria

  Age

  18 years and over

  People

  520 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT06679101 · EU 2024-516030-35-00